CannaMD

MARCH 4, 2020

The data that is collected in Releaf App is used for multiple research studies and helps physicians identify what products patients are finding most effective. The data that is collected in Releaf App is used for multiple research studies and helps physicians identify what products patients are finding most effective.

Patients 79

Patients Data Collective Treatment 79

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

SpeedWeed

MARCH 15, 2021

The Cannabis Software Stack Executive Summary is available for free download now. Existing Cannabis License Holders : Licensees can access information in the report to gauge the footprint of software vendors in order to make critical business decisions. a state’s potential addressable market) in 2020. Key Report Highlights.

Seed-To-Sale 52

Seed-To-Sale Media Research and Development Data 52

Cannabis Law Report

JUNE 24, 2021

Safeguard rights and accessibility for medical patients. Gather robust data and share it widely. The criminal justice system, historical economic persecution, and healthcare access are the three leading barriers to cannabis opportunity in the US. Establish equitable cannabis licensing systems.

Legalization 76

Legalization Data eCommerce Policy 76

Cannabis Law Report

DECEMBER 21, 2021

The rapid increase in the volume of enterprise data and growing automation of business processes across several end-use industries such as retail, manufacturing, healthcare, and transportation are expected to drive the demand for business software and services over the forecast period. billion in 2020 (Grandview Research). from 2021 to 2028.

Research and Development 52

Research and Development Supply Chain Data Business 52

The Cannigma

NOVEMBER 23, 2021

There is also a lack of access to healthcare professionals, and experts in the field, to guide patients through this complicated process. The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. Music by Desca. EG: For sure. Let’s listen.

Data 52

Data Patients Access Wellness and Beauty 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52